|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/00 | |
| A61K 39/00 | |||
| C12N 9/24 |
| (11) | Number of the document | 1786902 |
| (13) | Kind of document | T |
| (96) | European patent application number | 05790917.8 |
| Date of filing the European patent application | 2005-07-21 | |
| (97) | Date of publication of the European application | 2007-05-23 |
| (45) | Date of publication and mention of the grant of the patent | 2015-09-09 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2005/025831 |
| Date | 2005-07-21 |
| (87) | Number | WO 2006/031291 |
| Date | 2006-03-23 |
| (30) | Number | Date | Country code |
| 939262 | 2004-09-10 | US |
| (72) |
FANG Fang, US
MALAKHOV Michael, US
|
| (73) |
Ansun Biopharma, Inc.,
10665 Sorrento Valley Road, San Diego, California 92121,
US
|
| (54) | A NOVEL CLASS OF THERAPEUTIC PROTEIN BASED MOLECULES |
| A NOVEL CLASS OF THERAPEUTIC PROTEIN BASED MOLECULES |